Struggling With The Itch Caused By Eczema?
Researchers at Beth Israel Deaconess Medical Center are looking for adults, who have atopic dermatitis (eczema), to participate in a research study to explore new treatment options. Join our paid research study today!
Fast Facts
Diagnosed with Atopic Dermatitis for at least 1 year
willing to use adequate contraception if sexually active and avoid pregnancy or fathering children for duration of study
18-65 years old
Compensation Provided
Boston, MA metro area
Study Background
Our researchers want to investigate a possible treatment for itchy skin caused by Atopic dermatitis.
Atopic dermatitis, commonly known as eczema, is the most common chronic inflammatory skin disease. One hallmark of eczema is pruritis, or itchy skin, driving the “itch-scratch cycle” that further damages the skin. This study aims to test new treatment options for eczema using an oral medication called Zabedosertib.
You may qualify to enroll if you have been diagnosed with atopic dermatitis at least for a year. Participating in this research study may help researchers develop better treatment strategies for eczema. Join our compensated study today!
Study Background
Our researchers want to investigate a possible treatment for itchy skin caused by Atopic dermatitis.
Atopic dermatitis, commonly known as eczema, is the most common chronic inflammatory skin disease. One hallmark of eczema is pruritis, or itchy skin, driving the “itch-scratch cycle” that further damages the skin. This study aims to test new treatment options for eczema using an oral medication called Zabedosertib.
You may qualify to enroll if you have been diagnosed with atopic dermatitis at least for a year. Participating in this research study may help researchers develop better treatment strategies for eczema. Join our compensated study today!
Additional Information
You may qualify for this study if you meet the following criteria:
- Diagnosed with Atopic Dermatitis for at least 1 year
- Ages 18-65
- Willing to use adequate contraception if sexually active and avoid pregnancy or fathering children for duration of study
- Currently reside in Boston, MA metro area
Once enrolled, this study involves:
- 8 total visits, total study duration approximately 17-20 weeks
- Up to 28 days for screening period (visits 1 and 2)
- 1 safety follow-up visit (4 weeks after end of treatment)
- Optional biopsy substudy that comprises of 2 skin biopsies (baseline, week 12)
